Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Lupin and Medicis enter agreement for formulating multiple therapeutics

Aug. 2, 2011

Molecular Response and SuperGen enter translational oncology agreement

Aug. 2, 2011

Labopharm and Angelini Group restructure joint venture for Oleptro

Aug. 1, 2011

Lilly and Lupin enter collaboration for diabetes therapies

Aug. 1, 2011

Soligenix expands orBec partnership with Sigma-Tau

Aug. 1, 2011

Nippon Chemiphar discontinues development of cathepsin K inhibitor licensed to Velcura

Aug. 1, 2011

RaQualia grants rights for serotonin 5-HT4 partial agonist to CJ CheilJedang

Aug. 1, 2011

Invaron Pharmaceuticals obtains license for Striant

Aug. 1, 2011

Ribovax out-licenses SEBVI antibody technology

July 29, 2011

Immunotec and Nova Southeastern University to test autism treatment

July 29, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...